Clinical Trial Update: Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

View source ↗

Summary

A clinical trial evaluating perfusion CT to predict treatment response in hepatic malignancies has been terminated; the update does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Colorectal Cancer
• Hepatobiliary Cancers
• Hepatocellular Carcinoma
• Neuroendocrine Tumors

Snippet

Sponsor: Stanford University | Conditions: Neuroendocrine Tumors, Brain (Nervous System) Cancers | Status: TERMINATED